GlassScriptPhysician profile
Kevin D Myer
NPI 1831266006
$1,613.94
in general payments reported to CMS, 2019-2025
15 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.97 · 2021: $58.71 · 2022: $171 · 2023: $209 · 2024: $657 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $554.54 | 2021-2024 | Augment Injectable, Ortholoc 3di, Phalinx |
| Paratek Pharmaceuticals, INC. | $259.10 | 2024-2025 | Nuzyra |
| Averitas Pharma INC. | $191.74 | 2024-2025 | Qutenza |
| Medline Industries LP | $161.12 | 2025 | |
| Medtronic, INC. | $128.50 | 2023 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $84.58 | 2021-2025 | Motoband |
| Amgen INC. | $64.80 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $41.75 | 2025 | Renasys Touch |
| Abbvie INC. | $34.29 | 2024-2025 | |
| Reapplix INC. | $20.99 | 2025 | 3c Patch Kit - Box |
| Abbott Laboratories | $20.54 | 2025 | Eterna |
| Orthofix Medical, INC. | $17.64 | 2019 | |
| Ibsa Pharma INC. | $13.67 | 2024 | Tirosint, Licart |
| Pylant Medical | $11.33 | 2019 | |
| Advanced Oxygen Therapy INC. | $9.35 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Myer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.